Autopsy report · NCT00534898

Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients

“The study withdrawn due to lack financial support”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Beersheva Mental Health Center

Sponsor type

Government (non-US federal)

Conditions

Schizophrenia; Schizoaffective Disorder; Cognition

Interventions

Bexarotene; Fenretinide; Placebo

Sites

1

Countries

Israel

Trials that died the same way

• Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
  “The study was withdrawn due to lack of financial support.” (95% match in meaning)
• The Influence of Probiotics on Body Weight and Composition
  “study withdrawn due to funding” (88% match in meaning)
• Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure
  “Study withdrawn for financial issues” (88% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (86% match in meaning)
• Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
  “Funding for study was withdrawn” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.